Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Takeshi Taguchi is active.

Publication


Featured researches published by Takeshi Taguchi.


Journal of Clinical Apheresis | 2015

Immunoadsorption therapy for neuromyelitis optica spectrum disorders long after the acute phase

Masatake Kobayashi; Kazunori Nanri; Takeshi Taguchi; Tomoko Ishiko; Masaharu Yoshida; Noriko Yoshikawa; Kentaro Sugisaki; Nobuyuki Tanaka

Neuromyelitis optica (NMO) is a severe inflammatory demyelinating disease with exacerbations involving recurrent or bilateral optic neuritis and longitudinally extensive transverse myelitis. Pulse steroid therapy is recommended as the initial, acute‐phase treatment for NMO. If ineffective, treatment with plasma exchange (PE) should commence. However, no evidence exists to support the effectiveness of PE long after the acute phase. Immunoadsorption therapy (IA) eliminates pathogenic antibodies while sparing other plasma proteins. With IA, side effects of PE resulting from protein substitution can be avoided. However, whether IA is effective for NMO remains unclear. We describe a patient with anti‐aquaporin‐4‐positive myelitis who responded to IA using a tryptophan polyvinyl alcohol gel column that was begun 52 days after disease onset following the acute phase. Even long after the acute phase when symptoms appear to be stable, IA may be effective and should not be excluded as a treatment choice. J. Clin. Apheresis 30:43–45, 2015.


Diagnostic Pathology | 2011

Selective loss of Purkinje cells in a patient with anti-gliadin-antibody-positive autoimmune cerebellar ataxia

Kazunori Nanri; Makoto Shibuya; Takeshi Taguchi; Akira Hasegawa; Nobuyuki Tanaka

The patient was an 84-year-old woman who had the onset of truncal ataxia at age 77 and a history of Basedows disease. Her ataxic gait gradually deteriorated. She could not walk without support at age 81 and she was admitted to our hospital at age 83. Gaze-evoked nystagmus and dysarthria were observed. Mild ataxia was observed in all limbs. Her deep tendon reflex and sense of position were normal. IgA anti-gliadin antibody, IgG anti-gliadin antibody, anti-SS-A/Ro antibody, anti-SS-B/La antibody and anti-TPO antibody were positive. A conventional brain MRI did not show obvious cerebellar atrophy. However, MRI voxel based morphometry (VBM) and SPECT-eZIS revealed cortical cerebellar atrophy and reduced cerebellar blood flow. IVIg treatment was performed and was moderately effective. After her death at age 85, the patient was autopsied. Neuropathological findings were as follows: selective loss of Purkinje cells; no apparent degenerative change in the efferent pathways, such as the dentate nuclei or vestibular nuclei; no prominent inflammatory reaction. From these findings, we diagnosed this case as autoimmune cerebellar atrophy associated with gluten ataxia. All 3 autopsies previously reported on gluten ataxia have noted infiltration of inflammatory cells in the cerebellum.In this case, we postulated that the infiltration of inflammatory cells was not found because the patients condition was based on humoral immunity. The clinical conditions of gluten ataxia have not yet been properly elucidated, but are expected to be revealed as the number of autopsied cases increases.


Journal of Clinical Neuroscience | 2008

Transient hemiballism caused by a small lesion of the subthalamic nucleus

Hiroshi Nishioka; Takeshi Taguchi; Kazunori Nanri; Yukio Ikeda

Hemiballism is most commonly caused by ischemic stroke and most cases have a favorable prognosis. Lesions directly involving the subthalamic nucleus (STN) are the cause of a minority of cases but are usually associated with poor prognosis. We report two patients with a small STN lesion who presented with transient hemiballism. A small lesion confined to and only focally affecting the STN may cause hemiballism yet may have excellent outcome. Precise evaluation of the affected region with MRI is useful in predicting the prognosis.


Internal Medicine | 2016

Prevalence of Autoantibodies and the Efficacy of Immunotherapy for Autoimmune Cerebellar Ataxia.

Kazunori Nanri; Misaki Okuma; Saki Sato; Makoto Yoneda; Takeshi Taguchi; Hiroshi Mitoma; Junji Yamada; Sakae Unezaki; Tetsuo Nagatani; Shiho Otsubo; Mayumi Sugawara; Nobuyuki Tanaka; Hidehiro Mizusawa

OBJECTIVE Autoimmune cerebellar ataxias were recently reported to be treatable. However, the proportion of patients with cortical cerebellar atrophy of unknown etiology with autoimmune-associated cerebellar ataxia and the actual effectiveness of immunotherapy in these diseases remain unknown. METHODS We measured the level of autoantibodies (including anti-gliadin antibody, anti-glutamic acid decarboxylase (GAD) antibody, and anti-thyroid antibody) in 58 Japanese patients with cerebellar ataxia, excluding those with multiple system atrophy, hereditary spinocerebellar ataxia, cancer, or those who were receiving phenytoin, and the efficacy of immunotherapy was assessed. RESULTS Thirty-one of 58 (53%) patients were positive for anti-GAD antibody, anti-gliadin antibody, or anti-thyroid antibody. Seven of the 12 anti-gliadin antibody-positive patients, three of the four anti-GAD antibody-positive patients, and three of the six anti-thyroid antibody-positive patients responded well to immunotherapy, indicating that 59% of patients with ataxia-associated antibody-positive cerebellar ataxia undergoing immunotherapy responded well. CONCLUSION Some patients with cerebellar ataxia have autoimmune conditions and diagnosing autoimmune cerebellar ataxia is therefore an important component in the care of patients with this disease entity.


Rinsho Shinkeigaku | 2018

A case of meningeal carcinomatosis mimicking subarachnoid hemorrhage on MRI

Yoshihiko Okubo; Yuki Ueta; Takeshi Taguchi; Haruhisa Kato; Hiroo Terashi; Hitoshi Aizawa

We report a case of meningeal carcinomatosis that needed to be distinguished from subarachnoid hemorrhage. A 67-year-old female with acute severe headache was admitted to a previous hospital. Since high intensity signal was detected within the parietal cerebral sulci on the right side on brain FLAIR MRI, cerebral angiography was performed due to suspicion of subarachnoid hemorrhage. However, no vascular abnormality was observed. Then, cerebral spinal fluid was collected, which showed an increase in cell count, suggesting meningitis. She was transferred to our hospital for evaluation of neurological disease. After admission to our hospital, there was an episode of hematemesis. Upper gastrointestinal endoscopy was performed, and advanced gastric cancer was found. She was diagnosed as having meningeal carcinomatosis due to gastric cancer. Meningeal carcinomatosis should be considered in addition to subarachnoid hemorrhage when a patient with acute headache shows high intensity signal within the cerebral sulci on brain FLAIR MRI.


Neurology and Clinical Neuroscience | 2013

Superficial siderosis with cerebrospinal fluid leakage

Masatake Kobayashi; Kazunori Nanri; Hiroshi Oba; Tomoko Ishiko; Takeshi Taguchi; Nobuyuki Tanaka; Kenji Sato; Yukio Ikeda

The patient was a 73-year-old man with a history of traffic accident in 1999. In 2004, blood patch treatment was carried out for cerebrospinal fluid (CSF) hypovolemia. In 2009, he became aware of hearing loss and dizziness. T2*-weighted magnetic resonance images showed a symmetric hypointense rim partially delineating the cerebellum. CSF analysis showed xanthochromia and elevated red blood cell count. We diagnosed superficial siderosis (SS). We carried out computed tomography myelogram and magnetic resonance imaging of the full spine, and epidural fluid accumulation was detected from the second cervical vertebra to the 11th thoracic vertebra (Fig. 1). The 24-h residual rate on cisternal scintigraphy was decreased to 20.9%, suggesting CSF leakage. In the pathogenesis of SS with epidural fluid accumulation, a dural tear might be the source of bleeding, and it might also cause CSF hypovolemia. When SS is observed, it is important to detect fluid accumulation carefully with spinal magnetic resonance imaging to locate the site of bleeding. References


Internal Medicine | 2009

Intravenous immunoglobulin therapy for autoantibody-positive cerebellar ataxia.

Kazunori Nanri; Mitsunori Okita; Takeshi Taguchi; Tomoko Ishiko; Hirohiko Saito; Takao Otsuka; Hiroshi Mitoma; Kiyoshi Koizumi


The Cerebellum | 2013

Low-titer anti-GAD-antibody-positive cerebellar ataxia.

Kazunori Nanri; Hisayoshi Niwa; Hiroshi Mitoma; Asako Takei; Junko Ikeda; Toshihide Harada; Mitsunori Okita; Takeshi Taguchi; Hidehiro Mizusawa


Internal Medicine | 2010

Classification of cerebellar atrophy using voxel-based morphometry and SPECT with an easy Z-score imaging system.

Kazunori Nanri; Kiyoshi Koizumi; Hiroshi Mitoma; Takeshi Taguchi; Tomoko Ishiko; Takao Otsuka; Hiroshi Nishioka; Hidehiro Mizusawa


The Cerebellum | 2014

Gluten Ataxia in Japan

Kazunori Nanri; Hiroshi Mitoma; Masafumi Ihara; Nobuyuki Tanaka; Takeshi Taguchi; Tomoko Ishiko; Hidehiro Mizusawa

Collaboration


Dive into the Takeshi Taguchi's collaboration.

Top Co-Authors

Avatar

Kazunori Nanri

Tokyo Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Tomoko Ishiko

Tokyo Medical University

View shared research outputs
Top Co-Authors

Avatar

Hiroshi Mitoma

Tokyo Medical University

View shared research outputs
Top Co-Authors

Avatar

Hidehiro Mizusawa

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Akira Hasegawa

Tokyo Medical University

View shared research outputs
Top Co-Authors

Avatar

Hirohiko Saito

Tokyo Medical University

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge